Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.

ABSTRACT:

SUBMITTER: Wang H 

PROVIDER: S-EPMC8799711 | biostudies-literature | 2022 Jan

REPOSITORIES: biostudies-literature